Patient Registry Software Market By Registry type, By Software type, By Functionality, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Disease Registry
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Disease Registry Patient Registry Software Market by Type
4.2.4.1 Cardiovascular Registry Market size and forecast, by region
4.2.4.2 Diabetes Registry Market size and forecast, by region
4.2.4.3 Cancer Registry Market size and forecast, by region
4.2.4.4 Rare Disease Registry Market size and forecast, by region
4.2.4.5 Others Market size and forecast, by region
4.3 Health Service Registry
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Product Registry
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.4.4 Product Registry Patient Registry Software Market by Type
4.4.4.1 Medical device Registry Market size and forecast, by region
4.4.4.2 Drug Registry Market size and forecast, by region

CHAPTER 5: PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Standalone
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Integrated
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country

CHAPTER 6: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY
6.1 Overview
6.1.1 Market size and forecast
6.2 Population Health Management
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Health Information Exchange
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Patient Care Management
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Medical Research and Clinical Studies
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country

CHAPTER 7: PATIENT REGISTRY SOFTWARE MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Government and third party organizations
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Pharma, Biotech and Medical Device Companies
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country

CHAPTER 8: PATIENT REGISTRY SOFTWARE MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Registry type
8.2.2.1 North America Disease Registry Patient Registry Software Market by Type
8.2.2.2 North America Product Registry Patient Registry Software Market by Type
8.2.3 North America Market size and forecast, by Software type
8.2.4 North America Market size and forecast, by Functionality
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U. S.
8.2.6.1.1 Market size and forecast, by Registry type
8.2.6.1.2 Market size and forecast, by Software type
8.2.6.1.3 Market size and forecast, by Functionality
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Registry type
8.2.6.2.2 Market size and forecast, by Software type
8.2.6.2.3 Market size and forecast, by Functionality
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Registry type
8.2.6.3.2 Market size and forecast, by Software type
8.2.6.3.3 Market size and forecast, by Functionality
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Registry type
8.3.2.1 Europe Disease Registry Patient Registry Software Market by Type
8.3.2.2 Europe Product Registry Patient Registry Software Market by Type
8.3.3 Europe Market size and forecast, by Software type
8.3.4 Europe Market size and forecast, by Functionality
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Registry type
8.3.6.1.2 Market size and forecast, by Software type
8.3.6.1.3 Market size and forecast, by Functionality
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Registry type
8.3.6.2.2 Market size and forecast, by Software type
8.3.6.2.3 Market size and forecast, by Functionality
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Registry type
8.3.6.3.2 Market size and forecast, by Software type
8.3.6.3.3 Market size and forecast, by Functionality
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Registry type
8.3.6.4.2 Market size and forecast, by Software type
8.3.6.4.3 Market size and forecast, by Functionality
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Registry type
8.3.6.5.2 Market size and forecast, by Software type
8.3.6.5.3 Market size and forecast, by Functionality
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Registry type
8.3.6.6.2 Market size and forecast, by Software type
8.3.6.6.3 Market size and forecast, by Functionality
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Registry type
8.4.2.1 Asia-Pacific Disease Registry Patient Registry Software Market by Type
8.4.2.2 Asia-Pacific Product Registry Patient Registry Software Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Software type
8.4.4 Asia-Pacific Market size and forecast, by Functionality
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Registry type
8.4.6.1.2 Market size and forecast, by Software type
8.4.6.1.3 Market size and forecast, by Functionality
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Registry type
8.4.6.2.2 Market size and forecast, by Software type
8.4.6.2.3 Market size and forecast, by Functionality
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Registry type
8.4.6.3.2 Market size and forecast, by Software type
8.4.6.3.3 Market size and forecast, by Functionality
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Registry type
8.4.6.4.2 Market size and forecast, by Software type
8.4.6.4.3 Market size and forecast, by Functionality
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Registry type
8.4.6.5.2 Market size and forecast, by Software type
8.4.6.5.3 Market size and forecast, by Functionality
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Registry type
8.4.6.6.2 Market size and forecast, by Software type
8.4.6.6.3 Market size and forecast, by Functionality
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Registry type
8.5.2.1 LAMEA Disease Registry Patient Registry Software Market by Type
8.5.2.2 LAMEA Product Registry Patient Registry Software Market by Type
8.5.3 LAMEA Market size and forecast, by Software type
8.5.4 LAMEA Market size and forecast, by Functionality
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Registry type
8.5.6.1.2 Market size and forecast, by Software type
8.5.6.1.3 Market size and forecast, by Functionality
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Registry type
8.5.6.2.2 Market size and forecast, by Software type
8.5.6.2.3 Market size and forecast, by Functionality
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Registry type
8.5.6.3.2 Market size and forecast, by Software type
8.5.6.3.3 Market size and forecast, by Functionality
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Registry type
8.5.6.4.2 Market size and forecast, by Software type
8.5.6.4.3 Market size and forecast, by Functionality
8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES
10.1 Conduent, Inc.
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Dacima Software Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Elekta AB (pub)
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 FIGmd, Inc.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 IBM Corp
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 ImageTrend, Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 IQVIA Holdings
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 McKesson Corporation
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 OpenText Corporation
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Optum, Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 Ordinal Data, Inc.
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Premier, Inc.
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Patient Registry Software Market,' the patient registry software market was valued at $993.28 million in 2021, and is estimated to reach $2, 508.27 million by 2031, growing at a CAGR of 9.7% from 2022 to 2031.

There are different purposes for using of patient registries software. According to the National Institutes of Health, Registries can be used to recruit patients for clinical trials to learn about a particular disease or condition, to develop therapeutics, or to learn about population behavior patterns and their association with disease development. Patient registries can also be used to monitor outcomes and study best practices during the course of the treatment. They may pursue a specific, focused research agenda, may collect data for a limited time to answer a specific research question, or may collect data on an indefinite basis to answer a variety of existing and emerging research questions. Patient registries may also include the collection of tissue or blood samples collected in a variety of ways. The creation and use of researcher-generated patient registries has grown steadily for several decades. The examples of individual researcher-generated registries can be found at the AHRQ Registry of Patient Registries.

Major driving factors of patient registry software market size include increase in the usage of electronic health records (EHRs), rise in prevalence of chronic diseases, surge in government support for healthcare, rise in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations. Furthermore, increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries boost the growth of the market. However, concerns related to the security and privacy of the data and dearth of skilled resources hinder the market growth. Conversely, the increase in awareness regarding technologies is expected to create lucrative opportunities for the patient registry software market growth.

On the basis of registry type, the market is classified into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. The disease registry segment is projected to exhibit the fastest market growth during the forecast period, owing to advantages that are offered by these software and increased adoption of patient registry software.

On the basis of software type, the market is classified into standalone and integrated. The integrated segment is anticipated to grow at the highest rate, owing to surge in number of integrated software system adopted in hospitals and rise in prevalence of chronic conditions. Moreover, rise in preference of the cardiovascular diseases and cancer also helps in growth of the patient registry software market share.

On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. The medical research and clinical studies segment is anticipated to grow at the highest rate, owing to surge in demand for medical research and clinical studies related to various healthcare issues, which is mainly due to increase in the incidences of various diseases. Moreover, rise in number of hospital visits also contributes toward the growth of the market.

On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. The pharma, biotech and medical device companies segment is anticipated to grow at the highest rate, owing to surge in number of pharmaceutical, biotechnology and medical device companies, which is mainly due to increase in demand of pharmaceutical and biotechnology products.

On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). In 2021, North America was the dominant region, and is expected to remain dominant throughout the forecast period, owing to the patient registry software market trends like high prevalence rate of chronic diseases, and surge in number of treatment procedures performed in the region. However, Asia-Pacific is expected to witness highest CAGR during the analysis period, owing to presence of high populace countries such as India and China, which increases prevalence rate of chronic diseases, geriatric population, and number of pharmaceutical companies.

KEY FINDINGS OF STUDY

By registry type, the disease registry segment accounted for major market share of the global market in 2021.

On the basis of software type, the integrated segment accounted for largest market share in 2021 and is expected to remain dominant during the patient registry software market forecast period.

On the basis of functionality, the population health management segment accounted for largest market share in 2021 and is expected to remain dominant during the forecast period.

By end user, the pharma, biotech and medical device companies segment is expected to exhibit a prominent growth rate of 11.2% during the forecast period.

Region-wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 11.3% during the forecast period.

Companies Mentioned

• Conduent, Inc.
• Dacima Software Inc.
• Elekta Ab (Pub)
• Figmd, Inc.
• IBM Corp
• Imagetrend, Inc.
• Iqvia Holdings
• Mckesson Corporation
• Opentext Corporation
• Optum, Inc.
• Ordinal Data, Inc.
• Premier, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.